Health Level Seven International
Craig Lipset serves as the Co-Chair of the Decentralized Trials & Research Alliance (DTRA), focusing on enhancing patient-centered decentralized clinical trials and research. Lipset is also a thought leader at HLTH Inc., contributing to discussions on clinical trial innovation, while participating on advisory boards for i-Cubed and Every Cure, both aimed at advancing clinical research methodologies and drug repurposing. In academia, Lipset holds the position of Adjunct Assistant Professor at Rutgers University, teaching courses on clinical trials. Additionally, Lipset is involved with NODE.Health and the Project Vulcan Advisory Council, which work to streamline clinical research through digital evidence and data exchange standards. As a Fellow at DIA and Vice President of the Foundation For Sarcoidosis Research, Lipset is engaged in promoting better health outcomes. Further, Lipset serves as a Senior Advisor at Ardan Equity, focusing on growth in the healthcare software sector. Educational credentials include degrees from Columbia University and Brandeis University.
This person is not in any offices
Health Level Seven International
Founded in 1987, Health Level Seven (HL7) is an ANSI-accredited non-profit that empowers global health data interoperability by developing standards and enabling their adoption and implementation – for a world where everyone can securely access and use the right health data when and where they need it. Why HL7? http://bit.ly/1UTe5fO HL7 International LinkedIn group page: https://www.linkedin.com/groups/2478980